What is Iovance Biotherapeutics, Inc.'s notes payable current?

Iovance Biotherapeutics, Inc. (IOVA) reported notes payable current of $1M in Q1 2026.

How has Iovance Biotherapeutics, Inc.'s notes payable current changed year-over-year?

Iovance Biotherapeutics, Inc.'s notes payable current decreased by 0.0% year-over-year, from $1M to $1M.

Iovance Biotherapeutics, Inc. IOVA Notes Payable Current

Notes Payable Current at other companies

CarvanaCVNA

$229M-25.6%

Galaxy Digital Inc. Class A Common StockGLXY

$432.73M—

Willdan GroupWLDN

$2.5M0.0%

Andersen Group ANDG

$57.47M—

Sonida Senior LivingSNDA

$218.67M+1,396%

Navan, Inc. NAVN

$316K—

Other financials

Income statement

See full

Revenue$71.4M+44.8%

Gross profit$28.9M+338%

Operating income-$81.0M+33.1%

Net income-$79.0M+32.0%

EPS (diluted)-$0.19+47.2%

Balance sheet

See full

Cash & equivalents$196.5M+14.5%

Total debt$46.8M-11.3%

Total equity$721.8M-6.0%

Total assets$925.7M-4.2%

Cash flow

See full

Operating cash flow-$72.1M+30.5%

CapEx$6.6M+6.4%

Free cash flow-$78.7M+28.4%

Valuation

See full

Market cap$1.9B+32.4%

Profitability

See full

Gross margin36.7%+4.1pp

Operating margin-127.2%-31.0pp

Net margin-123.9%-28.4pp

FCF margin-106.8%-27.5pp

Returns & leverage

See full

Return on equity-47.5%-3.7pp

Debt / equity0.1×0.0×

Current ratio3.6×-0.6×

Where this comes from

Reported directly by Iovance Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:NotesPayableCurrent.

The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Iovance Biotherapeutics, Inc.'s notes payable current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Iovance Biotherapeutics, Inc.'s notes payable current?: Iovance Biotherapeutics, Inc. (IOVA) reported notes payable current of $1M in Q1 2026.
How has Iovance Biotherapeutics, Inc.'s notes payable current changed year-over-year?: Iovance Biotherapeutics, Inc.'s notes payable current decreased by 0.0% year-over-year, from $1M to $1M.